Search
Jaguar Health Inc
JAGXAdd to Watchlist
1.040USD
+0.074+7.63%
Close 07-29 16:00（ET）Quotes delayed by 15 min
386.86KMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-29No earnings forecast score is currently available for Jaguar Health Inc. The Pharmaceuticals industry's average is 7.86. The average price target is 16.00, with a high of 16.00 and a low of 16.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
16.000
Target Price
+2527.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Jaguar Health Inc
JAGX
0
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Jaguar Health Inc's expected revenue for the next quarter?
Jaguar Health Inc's expected revenue is 4.25M.
What is Jaguar Health Inc's price target?
Analysts forecast that Jaguar Health Inc's price target is USD 16.00, with the highest forecast at USD 16.00 and the lowest forecast at USD 16.00.
How have Jaguar Health IncJAGX's recent earnings per share performed?
The market expectation was USD -13.60, while Jaguar Health IncJAGX's earnings per share (EPS) for the previous quarter was USD -4.38. EPS for the next quarter is expected at USD -1.49.